Hypertension Journal 2014

Hypertension Journal 2014

September 17, 2019 0 By Bertrand Dibbert


(news jingle) – My name is Anna Dominiczak. I am Editor in Chief of “Hypertension”, and it is my pleasure to speak
to you about the journal. It’s been two years since
I have been doing the job of Editor in Chief, and it’s been a fantastic experience. The journal has been growing
over the last two years and this is a continuation of hard work of the previous editors and
also a very much team effort of all associate editors and the team led by Denise in our office. As you know, “Hypertension” has a very simple mission statement: we wish to be the best
hypertension journal in the world, and we are the best hypertension
journal in the world. So, we simply need to
make absolutely sure that this mission statement is
fulfilled for years to come. You might be aware that
our impact factor this year has gone significantly up, and it’s 7.632, the highest ever in the
history of the journal and the history of the
journal’s impact factor being recorded; that is since 1981. We publish more and more
clinically relevant papers, and you probably enjoy
our special development that we’ve had for last two years, which is Clinical Implications. These are three papers
which I select and they also are asked to produce
a summary which takes just one column on the
one page and a figure. These are very much enjoyed
by number of people who access them both electronically, accessing our website
and electronic pages, but also we know that readers
who prefer the printed pages enjoy this type of clinical
translational information for our journal. There are many other
initiatives that are ongoing, including more visibility in the media. We select papers that are media-friendly, of particular interest
to the wider society, and we would like all our
readers and our authors to tell us about events in “Hypertension”, papers in “Hypertension”, that should be shared
with general public more in the future. So I think the future is bright, “Hypertension” is a
very successful journal. We want your support as authors, readers, clinicians in hypertension. At the end of the day,
it is for our patients, patients with high blood pressure, that we do this work in the journal. Thank you for your attention.